Cellular Biology |
From the Metastasis Research Laboratory (A.B., K.B., V.C.), University of Liège, Liège, Belgium, and the Craniofacial and Skeletal Diseases Branch (B.F., N.S.F., F.A.R., M.F.Y., L.W.F.), National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md.
AbstractBone sialoprotein (BSP)
is a secreted glycoprotein primarily found in sites of
biomineralization. Recently, we demonstrated that BSP is strongly
upregulated in osteotropic cancers and particularly those that exhibit
microcalcifications. BSP contains an Arg-Gly-Asp (RGD) motif found in
other adhesive molecules that interact with cellular integrins. In
bone, BSP has been shown to mediate the attachment of osteoblasts and
osteoclasts via
vß3 integrin receptors.
Ligands for
vß3 integrin are considered to
play a central role during angiogenesis. Therefore, we used human
umbilical vein endothelial cells (HUVECs) to study the
potential role of BSP in angiogenesis. We found that purified
eukaryotic recombinant human BSP (rhBSP) is able to promote
both adhesion and chemotactic migration of HUVECs in a dose-dependent
manner. These interactions involve HUVEC
vß3 integrin receptors and the RGD domain
of BSP. Indeed, HUVECs attach to a recombinant BSP fragment containing
the RGD domain, whereas this response is not observed with the same
fragment in which RGD has been mutated to Lys-Ala-Glu (KAE). A cyclic
RGD BSP peptide inhibits both adhesion and migration of HUVECs to
rhBSP. Moreover, anti-
vß3 but not
anti-
vß5 monoclonal antibodies also
prevent BSP-mediated adhesion and migration of HUVECs. We observed that
both rhBSP and the RGD BSP recombinant fragment stimulated ongoing
angiogenesis on the chorioallantoic chick membrane assay. BSP
angiogenic activity was inhibited by
anti-
vß3 antibody, and the KAE BSP
fragment was inactive. Our findings represent the first report
implicating BSP in angiogenesis. BSP could play a critical role in
angiogenesis associated with bone formation and with tumor growth and
metastatic dissemination.
Key Words: bone sialoprotein angiogenesis integrins
This article has been cited by other articles:
![]() |
K. S. Gill, F. Beier, and H. A. Goldberg Rho-ROCK signaling differentially regulates chondrocyte spreading on fibronectin and bone sialoprotein Am J Physiol Cell Physiol, July 1, 2008; 295(1): C38 - C49. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Malaval, N. M. Wade-Gueye, M. Boudiffa, J. Fei, R. Zirngibl, F. Chen, N. Laroche, J.-P. Roux, B. Burt-Pichat, F. Duboeuf, et al. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis J. Exp. Med., May 12, 2008; 205(5): 1145 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. de Leval, T. Dassesse, J.-M. Dogne, D. Waltregny, A. Bellahcene, V. Benoit, B. Pirotte, and V. Castronovo Evaluation of Original Dual Thromboxane A2 Modulators as Antiangiogenic Agents J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1057 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Su, A. K. Bansal, R. Mantovani, and J. Sodek Recruitment of Nuclear Factor Y to the Inverted CCAAT Element (ICE) by c-Jun and E1A Stimulates Basal Transcription of the Bone Sialoprotein Gene in Osteosarcoma Cells J. Biol. Chem., November 18, 2005; 280(46): 38365 - 38375. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.D.M. Collett and A.E. Canfield Angiogenesis and Pericytes in the Initiation of Ectopic Calcification Circ. Res., May 13, 2005; 96(9): 930 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Fisher, A. Jain, M. Tayback, and N. S. Fedarko Small Integrin Binding Ligand N-Linked Glycoprotein Gene Family Expression in Different Cancers Clin. Cancer Res., December 15, 2004; 10(24): 8501 - 8511. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-S. Wang, C.-J. Wang, Y.-J. Chen, P.-R. Chang, Y.-T. Huang, Y.-C. Sun, H.-C. Huang, Y.-J. Yang, and K. D. Yang Ras Induction of Superoxide Activates ERK-dependent Angiogenic Transcription Factor HIF-1{alpha} and VEGF-A Expression in Shock Wave-stimulated Osteoblasts J. Biol. Chem., March 12, 2004; 279(11): 10331 - 10337. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Barnes, A. Javed, S. M. Waller, M. H. Kamal, K. E. Hebert, M. Q. Hassan, A. Bellahcene, A. J. van Wijnen, M. F. Young, J. B. Lian, et al. Osteoblast-related Transcription Factors Runx2 (Cbfa1/AML3) and MSX2 Mediate the Expression of Bone Sialoprotein in Human Metastatic Breast Cancer Cells Cancer Res., May 15, 2003; 63(10): 2631 - 2637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wood, K. Bonjean, S. Ruetz, A. Bellahcene, L. Devy, J. M. Foidart, V. Castronovo, and J. R. Green Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1055 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dong and P. J. Goldschmidt-Clermont Bone Sialoprotein and the Paradox of Angiogenesis Versus Atherosclerosis Circ. Res., April 28, 2000; 86(8): 827 - 828. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |